News Hub | News Direct

All Industries


Article thumbnail News Release

Lado Okhotnikov, CEO of Meta Force presented a pilot release of the superhero comic and talked about further developments

Cartel Blue, Inc

In early July 2024, Meta Force released a pilot of the superhero comic and announced ambitious plans to create its own Cinematic Universe (or Extended Universe, or in this case MFEU). Meta Force is a company developing its blockchain-based metaverse Neo Dao. The implementation of a creative project may have seemed like a marketing move, but Lado Okhotnikov, CEO of Meta Force announced plans to release a comic series and create a large-scale MFEU. Lado Okhotnikov presents the comic: Heroes of the New Generation Currently, there is a very well-established idea of what a superhero should be. Marvel, DC, and Japanese manga dominate the media, forming “right” character images. The heroes proposed by Meta Force depart from traditions and stereotypes, they operate in a new world where metaverses become part of our lives. And this is no longer the assumption nor a creative idea of the writers, but reality. The superhero of the Neo Dao metaverse largely transmits the ideas and beliefs of Lado Okhotnikov himself, and the comic book, among others, becomes manifest. Moreover, the pilot is partly autobiographical, similar events happened in the life of the founder of Meta Force, and many heroes have real prototypes. All this is well described by the Meta Force’s slogan: “Virtuality meets reality”. The first pilot gives a general idea of the new hero. He receives superpowers not by chance, not as a gift of fate, but as a result of work and self-improvement. Evil also appears not in the form of traditional villains, but as something mysterious and existential, secretly governing our civilization. The main character’s mission is not so much to defeat enemies physically, but to maintain the balance of the Universe. The main character, Mr. Dao, is philosophical, and charismatic, and has a unique style, in the story, action is successfully combined with reflections. MFEU The basic initial element of modern cineverses was a comic book, around it new formats were built such as cartoons, series, and feature films. That’s how Marvel and DC started. Lado Okhotnikov emphasizes that the comic is the first step in creating its own MFEU. The release dates of the comic continuation and new formats are not specified, it is claimed that this will be soon. About Company Meta Force is the company that created the DeFi platform and developer of Neo Dao metaverse. In two years of operation, the number of users exceeded two million. Lado Okhotnikov is the founder and CEO of Meta Force. Based on Dan Michael’s materials The head of the Meta Force Press Center press@meta-force.space Disclaimer: The Press Release content is being provided by CartelBlue Contact Details Meta Force Dan Michael +1 786-814-1818 press@meta-force.space Company Website https://meta-force.space/

August 27, 2024 07:04 AM Eastern Daylight Time

Article thumbnail News Release

How Seniors Can Benefit from Flip Phones

Spark Metro

In a world increasingly dominated by smartphones and constant connectivity, the simplicity of flip phones remains a compelling choice, particularly for seniors. While modern smartphones offer a multitude of features, their complexity can often be overwhelming for those who prioritize ease of use and straightforward functionality. For seniors, the balance between staying connected and maintaining simplicity is crucial, making flip phones an ideal solution. This article explores the many advantages of flip phones for seniors, highlighting how these devices offer a perfect blend of traditional simplicity and modern technology. The Appeal of Simplicity One of the most significant advantages of flip phones for seniors is their simplicity. Unlike smartphones, which require navigating complex menus and apps, flip phones offer a more straightforward interface. The act of flipping open the phone to answer a call and closing it to hang up is intuitive and familiar, providing a sense of nostalgia and comfort to many users. This simplicity reduces the learning curve, allowing seniors to use their phones confidently without needing extensive technical knowledge. Moreover, the tactile buttons on flip phones are often larger and more spaced out than those on smartphones, making them easier to press. This is particularly important for seniors who may struggle with dexterity or have vision impairments. The physical feedback of pressing a button, as opposed to the touchscreens of smartphones, adds to the ease of use, ensuring that seniors can make calls and send texts with minimal frustration. Enhanced Security and Privacy Another key advantage of flip phones for seniors is the enhanced security and privacy they offer. Smartphones are often vulnerable to various security threats, from phishing scams to malware, due to their internet connectivity and app usage. In contrast, flip phones have limited internet capabilities, significantly reducing the risk of cyber threats. For seniors who may not be as tech-savvy or aware of online risks, this limitation becomes a protective feature. Furthermore, flip phones typically do not store as much personal information as smartphones, which decreases the potential impact of losing the device. Seniors can feel more secure knowing that their personal data is less likely to be compromised if their phone is misplaced or stolen. This peace of mind is invaluable for those who prioritize security and privacy. Superior Battery Life Battery life is another area where flip phones excel, making them particularly well-suited for seniors. Smartphones are notorious for their relatively short battery life, often requiring daily charging due to their power-hungry apps and features. On the other hand, flip phones are designed with efficiency in mind, and their limited features contribute to significantly longer battery life. For seniors, the ability to go several days without needing to charge their phone is a major advantage. It reduces the hassle of constantly monitoring battery levels and ensures that their phone is always ready for use, particularly in emergencies. This reliability is a crucial factor for seniors who may not want to worry about their phone dying at an inconvenient time. Durability and Robust Design Flip phones are also known for their durability, a feature that is particularly important for seniors. The robust design of flip phones makes them less susceptible to damage from drops and other accidents, which are common concerns for users of all ages. The clamshell design not only protects the screen when the phone is closed but also adds a layer of protection against everyday wear and tear. This durability means that seniors can use their flip phones for extended periods without the need for frequent repairs or replacements. The sturdy construction of flip phones also makes them easier to handle, reducing the likelihood of accidental drops. For seniors, the combination of durability and ease of use ensures that their phone remains a reliable companion in their daily lives. Choosing the Right Flip Phone When selecting a flip phone for a senior, it's essential to consider specific features that cater to their needs. User-friendly features, reliable service, and a robust design are all critical factors to ensure that the phone meets their requirements. For instance, the Consumer Cellular IRIS Flip is an excellent option for seniors, offering a range of features designed with ease of use in mind. The large, easy-to-read display, intuitive navigation, and enhanced sound quality make it particularly suitable for those with vision or hearing impairments. Additionally, the IRIS Flip includes emergency response features, providing an added layer of security for seniors who may need assistance quickly. Its durable design ensures that it can withstand daily use, while the extended battery life means that seniors can rely on their phone to be ready when they need it most. The Importance of Reliable Service In addition to selecting a phone with the right features, it's also crucial to choose a provider that offers reliable service. For seniors, having a dependable network is essential for staying connected with family, friends, and emergency services. When considering a flip phone, ensure that the provider offers strong coverage in your area and has a reputation for excellent customer service. A good provider will also offer flexible plans that cater to the needs of seniors, such as low-cost options for those who primarily use their phone for calls and texts. This flexibility ensures that seniors are not paying for features they do not need, making their phone plan more affordable and tailored to their usage patterns. The Modern Benefits of a Traditional Design While flip phones may seem like a relic of the past, they continue to offer significant advantages in the digital age, especially for seniors. Their simplicity, enhanced security, superior battery life, and durability make them an attractive option for those who value straightforward, reliable communication. In addition to these benefits, modern flip phones have incorporated certain technological advancements that enhance their functionality without compromising their user-friendly design. Features such as voice commands, text-to-speech, and enhanced sound quality have been integrated into many flip phones, providing seniors with the convenience of modern technology while maintaining the simplicity they prefer. Conclusion For seniors, the choice of a mobile phone should prioritize ease of use, reliability, and security. Flip phones, with their intuitive design and practical features, offer a compelling solution that meets these needs. While smartphones dominate the market with their endless apps and features, the straightforward nature of flip phones provides a refreshing alternative, ensuring that seniors can stay connected without the complexity and distractions of more advanced devices. The Consumer Cellular IRIS Flip exemplifies the best of both worlds, combining the simplicity of a flip phone with carefully selected modern features that enhance usability and safety. By choosing the right flip phone, seniors can enjoy the benefits of staying connected while maintaining control over their digital experience. Contact Details Alex +1 302-597-6768 Apexreviews154@gmail.com

August 27, 2024 03:52 AM Eastern Daylight Time

Image
Article thumbnail News Release

BestGrowthStocks.Com Issues Comprehensive Analysis of Momentus Inc. Highlighting Competitive Advantages

Momentus,Inc

NEW YORK, NY / NewsDirect / August 26th, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive analysis of Momentus a U.S. commercial space company that offers satellite buses, transportation, and other in-space infrastructure services. Momentus Inc. (NASDAQ: MNTS) has garnered significant investor attention recently. Best Growth Stock's full report offers an analysis of Momentus’ operations, competitive advantages, potential catalysts, growth drivers, financials, share structure, chart setup with support and resistance levels, and more. Access this full analysis free here: https://bestgrowthstocks.com/access-momentus-analysis/ Access this full analysis free here: https://bestgrowthstocks.com/access-momentus-analysis/ About Momentus Momentus is a U.S. commercial space company that offers commercial satellite buses and in-space infrastructure services including in-space transportation, hosted payloads, and other in-orbit services. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.Com SOURCE: BestGrowthStocks.Com Contact Details Steve Macalbry Editor@bestgrowthstocks.com

August 26, 2024 01:51 PM Eastern Daylight Time

Image
Article thumbnail News Release

Minerva Surgical Launches Next Generation Symphion Fluid Management Accessory with Fluid Deficit Readout

Minerva Surgical, Inc.

Minerva Surgical, a manufacturer and distributor of minimally invasive gynecologic surgical technologies, today announced the launch of the Symphion Fluid Deficit Readout, an optional accessory that provides fluid deficit volume readings during operative hysteroscopy procedures. Operative hysteroscopy is a surgical procedure that requires precise fluid management to prevent complications. The Symphion Fluid Deficit Readout, which is intended for use with the Symphion Operative Hysteroscopy System, automatically calculates the fluid deficit during the procedure by measuring the weight of the saline bag throughout the procedure in real time and converting the weight measurement into fluid volume readings. Additional key features of the Symphion Fluid Deficit Readout include a fluid deficit accuracy within +/- 50mL, a user-friendly interface with an intuitive display for easy operation, and a compact design that allows for quick set up with the Symphion controller. “Continuous innovation with a focus on enhancing patient safety has always been the primary objective for Minerva Surgical. The Symphion Operative Hysteroscopy System is intended to volumetrically limit a patient’s exposure to fluid so the risk of fluid absorption and overload can be avoided. With the introduction of the Symphion Fluid Deficit Readout, the system has a new layer of procedural safety to complement the unprecedented precision during uterine cavity tissue resection.”, states Minerva Surgical Chief Medical Officer Eugene Skalnyi, M.D. Along with the Symphion Fluid Deficit Readout, Minerva Surgical is launching a compatible, next generation of Fluid Management Accessory called INFINITY. Together, the Symphion line extensions are the newest additions to the Minerva Surgical portfolio of minimally invasive technologies. The company is committed to advancing gynecologic surgery and providing solutions that enhance outcomes. About Minerva Surgical, Inc. Minerva Surgical is a technology enabled medical device company focused on developing, manufacturing, distributing, and commercializing minimally invasive solutions to meet the distinct pelvic healthcare needs of women. The Company has established a broad product line of minimally invasive alternatives to hysterectomy, which include solutions to detect and address common causes of Abnormal Uterine Bleeding (AUB). The Minerva Surgical pelvic health solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the anatomy by avoiding unnecessary hysterectomies. For more information about the innovative medical devices of Minerva Surgical, please visit www.MinervaSurgical.com. Contact Details Kevin Tracey +1 855-646-7874 kevin.tracey@minervasurgical.com Company Website https://minervasurgical.com/

August 26, 2024 10:00 AM Eastern Daylight Time

Article thumbnail News Release

AmeriLife’s Senior Market Advisors Welcomes Parker Marketing Insurance to Expand Presence in the Medicare Advantage and Final Expense Markets

AmeriLife

Senior Market Advisors (SMA), a fast-growing field marketing organization (FMO) in the insurance space and an affiliate of AmeriLife Group, LLC (“AmeriLife”), announced today that it has completed its acquisition of Parker Marketing Insurance (“PMI”). Per the agreement, terms of the deal were not disclosed. “Daniel [Parker] and his team represent the kind of customer-focused care that we promote in every interaction our affiliated agents and agencies have with their clients,” said Joshua Borders, CEO of Senior Market Advisors. “This partnership represents our shared values in meeting people where they are in their health insurance journey and helping them safeguard their assets for some of life’s unexpected events.” Inspired by his experiences and what he learned from his father, Parker established his first insurance agency in 2016, focused on replicating a successful final expense business into the Medicare Advantage market. This pivotal decision led to PMI’s Legacy Chassis—a primary brokerage model that benefits agents through a tiered lump sum model, enhancing recruitment efforts. “AmeriLife’s distribution platform offers robust layers of professionalism to ensure success for PMI’s agents and customers,” said Daniel Parker, owner and president of Parker Marketing Insurance. “This partnership will fuel my long-term vision, allowing me to continue my life’s work for the people I serve, enabling continued growth, and enhancing agent success emphasized by the power and unity of AmeriLife’s core values that prioritize the needs and success of others.” PMI’s growing, nationwide agent network—specifically, across the southeast in Mississippi, Georgia, and Florida—is a testament to its focus and dedication to talent acquisition and best-in-class training protocols, which have developed some of the region’s top producers. AmeriLife provides partners with a business environment and distribution network characterized by efficiency, value, and access to teams of dedicated professionals working together to enhance their platform with productivity and profitability. This proves especially advantageous for companies like PMI focused on the Medicare and final expense sectors, where consumers search for peace of mind and customized solutions to address their healthcare needs and end-of-life expenses. "Seeing our collaboration with Senior Market Advisors flourish through the years, and now with the inclusion of Parker Marketing Insurance, is exciting," added Scotty Elliott, Chief Distribution Officer of Health for AmeriLife. "This expansion highlights the robust nature of our expanding Health Distribution network, enabling us to assist more beneficiaries and establish new benchmarks in top-tier customer service within the industry." ### About Parker Marketing Insurance Parker Marketing Insurance helps people navigate the complex world of insurance, focusing on Medicare Advantage, Medicare Supplement, Medicare Part D, Dental & Vision Insurance, Hospital Indemnity, and Final Expense. Based in Meridian, MS, Parker Marketing Insurance is staffed by proven insurance professionals committed to providing consumers with highly personalized service. For more information, visit www.pmiagents.com. About Senior Market Advisors Senior Market Advisors (SMA) has been people over profits since 2007, by hard work and a commitment to “doing right” by the consumer. We have certainly knocked on our fair share of doors. We know the grit and determination involved in becoming a career agent. As a result, we are a fast-growing FMO, doubling our business each year for the past five years. For more information, visit us online at www.SeniorMarketAdvisors.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a distribution network of over 300,000 insurance agents, financial professionals, and over 100 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn. Contact Details AmeriLife Jeff Maldonado media@amerilife.com Partnership Inquiries Patrick Nichols corporatedevelopment@amerilife.com Company Website https://amerilife.com/

August 26, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Linqto’s Plan To Bring More Wealth Generation Opportunities To A Generation Of Investors That’s Wary Of Traditional Financial Institutions

Benzinga

By Kyle Anthony, Benzinga A recent Wall Street Journal highlighted that Millennials, in general, don’t trust traditional financial institutions. The disappointment that individuals within the Millennial and Generation Z demographic have towards traditional financial institutions is partly borne from their lived experience, as over the past two decades, they have lived through the Financial Crisis of 2007-2008, read congressional hearing transcripts about Citadel Securities' involvement in the Robinhood (NASDAQ: HOOD) “Meme Stock” controversy and seen the failure of three banks, namely, Signature Bank, Silicon Valley Bank and First Republic Bank, which stoked fear in equity markets and initiated a run on the bank in certain regions. Despite the adverse nature of the previously mentioned events, young people remain optimistic about their financial future, with 58% of Gen Z and 49% of Millennials expecting their financial situation to improve this year, according to a Bankrate survey. However, one concern among many is the built-in exclusivity and inaccessibility of many lucrative financial investments, and many young people are eschewing traditional asset classes, opting to use alternative investments to build their wealth. Against this backdrop, Linqto, a San Jose, California-based firm, wants to reshape the financial landscape by providing individuals access to private investments before they become publicly traded. Providing Wealth-Generating Opportunities For Young Investors A recent article by the World Economic Forum found that young people are actively investing. The World Economic Forum’s Global Retail Investor Survey found that 70% of retail investors are under the age of 45. With Millennials and Generation Z having lived through the ‘venture capital era’ and witnessed the entrepreneurial rise of Facebook, now called Meta Platforms (NASDAQ: META), Uber (NYSE: UBER) and Airbnb (NASDAQ: ABNB) – companies that grew from innovative upstarts to industry leaders – many young people have an appreciation and understanding as to how being an early, pre-IPO investor in private companies can lead to generational wealth. Given the wealth generation that can be attained through private market investments, Linqto's mission is to make investing in private companies as easy and accessible as investing in the public stock market. The platform features high-growth, technology-driven companies that they believe will go public or be acquired within five years. Accessing Private Markets With Linqto Linqto's approach to private market investing is distinct from its peers. First, the company primarily invests in mid-to-late-stage private companies within the technology industry. Selected firms must generate a minimum revenue amount with institutional venture capital or private equity investor backing. Linqto seeks to invest in visionary leaders and management teams with a proven track record of bringing timely products and services to market. The platform's investment thematic focus generally falls within the technology sub-verticals of artificial intelligence, blockchain and digital assets, enterprise software, networking and IoT, hardware and FinTech. Secondly, Linqto conducts in-depth due diligence on the firms it includes on its platform as it invests alongside its investors. By investing first and ensuring that Linqto has skin in the game, the firm can streamline the investment process, making it as easy as pointing and clicking to participate in the investment opportunities presented on the platform. Leveraging its in-house research expertise and evaluation capabilities, Linqto says it can offer access to top private companies with industry-low minimums and no fees. To learn more about Linqto’s investment offerings, click here. Finally, Linqto says its fee structure is also a key differentiator, as it is a zero-fee investment management platform. Given that the company purchases shares in large quantities from founders, employees and investors, it receives shares at a negotiated price. Linqto can then make smaller quantities of its shareholdings available to investors at a reasonable markup, thus eliminating the need for further follow-on fees for the investor. Historically, investing in a private company required individuals to invest at least $100,000. Linqto's initial minimum investment amount is $2,500, with subsequent investment amounts being $5,000. In comparison to the pricing structure of other private investment platforms, such as Forge Global Holdings (NYSE: FRGE), EquityZen and HIIVE, Linqto’s fee structure is very advantageous to retail investors desiring access to private investment opportunities. Furthermore, the self-directed investment platforms of Charles Schwab Corp. (NYSE: SCHW) and Robinhood (NASDAQ: HOOD) primarily cater to public equity investments, not private markets. Linqto: A New Avenue For Wealth Generation Linqto plans to revolutionize the investment journey in the private market by making it affordable, accessible and easy. With many companies remaining private for longer, Linqto’s platform is a new avenue through which young investors can gain early, pre-IPO access to companies that could potentially be poised to be industry leaders. As demand for private investments grows, Linqto’s platform can help investors looking to broaden their investment opportunities in a turnkey manner. To learn more and begin investing with Linqto, click here! Featured photo by Joshua Mayo on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 26, 2024 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Wolfpack Financial Has A Plan To Help Millennials And Gen Z Attain Their American Dream

Benzinga

By Anthony Termini, Benzinga Many Americans aged 18 to 27 either still live with their parents or rely on them for some financial support, according to a recent survey conducted by Bank of America. Tax and accounting consultants, Ernst & Young point out in a similar survey that more than half of GenZers say they are worried about not having enough money. In 2021 an article on the HuffPost website, explained how "millennials are facing the scariest financial future of any generation since the Great Depression." Prior to that, The Wall Street Journal conducted a survey that found "more than half of millennials surveyed feel overwhelmed by financial obligations." Their survey also noted that they don’t trust traditional financial institutions. Layered atop these sentiments is the reality that the way Americans earn a living is changing. According to management consultants McKinsey & Company, in 2022, some 58 million Americans identified themselves as independent (or gig) workers. TechReport.com notes that “over two-thirds of full-time gig workers find it a more secure form of employment than a regular job.” All of this seems to support what think tank New America, has reported. They found that in general, "Americans believe the American Dream… is becoming more difficult to attain." Amid such a landscape, one company may offer Millennials and Gen Zers a reason to feel optimistic about their financial futures. Wolfpack Financial Is Poised To Roll Out A Novel Approach To Investing Wolfpack Financial is a native app investment company focused on helping Millennials and Gen Zers control their finances and build generational wealth. The company, incorporated in Delaware with headquarters in New York, is not a traditional brokerage. Wolfpack offers an investment opportunity with multiple benefits for beginning and inexperienced investors. For example, the app makes it possible for an investor to open an account with a minimum of $5. What’s more, Wolfpack offers up to $50 in rewards to new customers meeting certain conditions who download the mobile app and fund their accounts with a minimum of $100. These same customers also automatically receive pre-approval for up to $2,000 in “Booster Loans” and priority access to them when they are launched later this year. Wolfpack’s Booster Loan program is one of the features that makes the app unique and particularly beneficial for the young customer base the company caters to. Booster Loans are a type of lending product that gives investors an opportunity to augment their cash purchases. The patent-pending innovation is a Buy-Now-Pay-Later system for buying stocks and ETFs. Wolfpack’s technology allows a customer to use smart leverage to purchase assets and then pay back the borrowed funds over a fixed 10-week repayment schedule. Booster Loans make it possible for an investor with $100 cash to invest up to $200 in a stock or ETF. Individual Wolfpack customers enjoy this unique investment opportunity, and the company also has an enterprise version it intends to license to banks and brokerage firms that don’t have a similar offering or functionality. Wolfpack notes that more than 90% of such U.S. institutions fall into that category, which results in cash outflows to other companies that do provide those services. Booster Loans are the only fully collateralized Buy-Now-Pay-Later lending product on the market, says Wolfpack, and the company will use it to help its strategic partners be more competitive with firms like Robinhood Markets (NASDAQ: HOOD) or WeBull. Another factor that makes Wolfpack unique in the industry is that there are no penalties for consumers using the Wolfpack app. The company also offers commission-free trades and fractional share trading and lets investors buy securities for as little as $5.00 per trade. Wolfpack prides itself on its product, noting that Booster Loans are a better alternative to personal loans, credit cards and traditional margin lending because of its lower interest rate. Why Millennials And Gen Zers May Want To Begin Their Investment Journeys Now While the financial stress felt by Millennials and Gen Zers is real, there is still much for them to be optimistic about. Collectively, they stand to benefit from one of the greatest wealth transfers in history. Some $84 trillion is expected to be inherited by these Americans in the next 20 years – about $16 trillion of that will be transferred in the next decade. Wolfpack believes that an important part of being able to manage that future wealth can be gained from the investment experience and education it offers to the current generation of beginning and inexperienced investors. These may be some of the greatest benefits Wolfpack users get from the app. Investment information about Wolfpack is available on the Wefunder website, and those interested in the Rewards and Priority Access being offered to new account holders should visit the company’s website. Featured photo by Nattanan Kanchanaprat from Pixabay. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 26, 2024 08:50 AM Eastern Daylight Time

Image
Article thumbnail News Release

Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma

Benzinga

By Kyle Anthony, Benzinga The growing prevalence of cancer is not limited to adults; it is also afflicting children. An estimated 15,780 children between birth and 19 years of age are diagnosed with cancer each year in the U.S., according to the American Childhood Cancer Organization. Approximately 1 in 285 children in the U.S. will be diagnosed with cancer before their 20th birthday. Globally, there are more than 300,000 children diagnosed with cancer each year, and the rate of childhood cancer is slowly rising; cancer cases increased to 177 per million in 2019 from 165 per million in 2003. Recently, Theriva Biologics (AMEX: TOVX), the clinical-stage immuno-oncology company developing therapies for difficult-to-treat cancers, was granted Rare Pediatric Drug Designation (RPDD) by the U.S. Food and Drug Administration (FDA) for VCN-01 for the treatment of retinoblastoma; the most common type of eye cancer in children. Retinoblastoma Presents Significant Treatment Challenges Retinoblastoma is a tumor that originates in the retina and accounts for approximately 2% of all childhood cancers. Some 200 to 300 children are diagnosed each year in the U.S., and the cancer is most common among infants and young children. The average age of a child when diagnosed is two years of age. Approximately three out of four children with retinoblastoma have a tumor in only one eye (known as unilateral retinoblastoma). When both eyes are affected it is known as bilateral retinoblastoma. Although the chances of developing retinoblastoma are statistically low, the challenge of preserving life while preventing the loss of an eye, blindness, and other severe consequences that diminish both lifespan and quality of life remains significant. Furthermore, in low-resource countries, children with retinoblastoma face a higher risk of losing their eyes and succumbing to metastatic disease. Recently, market research and industry consulting firm Spherical Insights assessed the global retinoblastoma treatment market size to be $2.5 billion in 2023; and it is expected to grow to $3.8 billion by 2033. Rare Pediatric Drug Designation For VCN-01 As the name suggests, the Rare Pediatric Drug Designation is a special status given to drugs explicitly developed for treating rare diseases that affect children. This designation is part of a broader effort to encourage the development of medications for conditions not commonly addressed due to the small number of patients, particularly in the pediatric population. For Theriva Biologics, this designation comes with a key incentive: if a Biologics License Application for VCN-01 for the treatment of retinoblastoma is approved by the FDA, Theriva says it may be eligible to receive a Priority Review Voucher (PRV) that can be redeemed to receive a priority review for any subsequent marketing application or may be transferred or sold. PRVs have previously been sold by different companies for around $100M. “The FDA’s decision to grant rare pediatric drug designation to VCN-01 highlights the urgent need for new treatment options for pediatric patients with retinoblastoma. We are encouraged by this important step forward and, in parallel, continue to work closely with leading physicians and regulatory agencies to refine our clinical strategy for VCN-01 as an adjunct to chemotherapy in pediatric patients with advanced retinoblastoma,” said Steven A. Shallcross, CEO of Theriva Biologics. “Most recently, results from the investigator-sponsored Phase 1 trial evaluating the safety and activity of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma were determined to be positive by the study Monitoring Committee. Data from this study will further inform our clinical development pathway in this area of high unmet need,” he said. With VCN-01 receiving RPDD from the U.S. FDA, this milestone speaks to the drug's efficacy and long-run potential. As such, the social benefit that Theriva Biologics provides could continue to grow and have increased industry resonance. Featured photo by Ani Kolleshi on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 26, 2024 08:45 AM Eastern Daylight Time

Image
Article thumbnail News Release

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack’s Plans To Transform The Continuous Glucose Monitoring Market

Benzinga

By Meg Flippin, Benzinga Managing diabetes has gotten an overhaul thanks to continuous glucose monitoring devices (CGM). Glucotrack Inc. (NASDAQ: GCTK), the Rutherford, New Jersey medical technology company that makes a continuous blood glucose monitoring (CBGM) device, is seeking to position itself to transform the glucose monitoring market. It is doing so through what it says is a game-changing medical technology that overcomes the challenges of the existing devices on the market, including the lack of real-time accuracy, the need for frequent sensor changes and concerns regarding comfort and wearability. Glucotrack’s implantable Continuous Blood Glucose Monitor (CBGM) measures glucose in the blood, something no other known competitor is offering to date. By measuring glucose in the blood instead of glucose in interstitial fluids – which is what most other devices measure – users get an accurate, real-time reading. Plus, Glucotrack’s implant can last up to three years, compared to less than one year for many of the continuous glucose monitoring (CGM) devices on the market. Patients don’t have to worry about sticking an adhesive to their body or be concerned about it falling off during physical activity, whether it's swimming or hot yoga. The CBGM, which also requires minimal calibration, eliminates the hassle and discomfort of a wearable that requires frequent replacement, the company said. Making The Rounds Glucotrack has been busy getting the word out about the potential of its CBGM. In June, it presented two posters at the American Diabetes Association (ADA) 84th Scientific Sessions discussing preclinical animal studies and a sensor longevity simulation modeling for its CBGM. The ADA Scientific Sessions is one of the premier diabetes conferences which provides a platform for the latest advancements in diabetes research, prevention and care. This annual meeting provides researchers and healthcare professionals with the opportunity to share ideas and learn about cutting-edge technologies and breakthroughs in diabetes research and diabetes-related conditions. Glucotrack also presented an emerging science industry poster at the Association of Diabetes Care and Education Specialists annual conference, which took place from Aug. 9 to 12. The poster presented market research data on the acceptance of the company’s CBGM concept among people with type 1 and type 2 diabetes. It highlighted that out of 757 respondents with type 1 and type 2 diabetes using a variety of insulin regimens, there was a positive sentiment towards the CBGM concept, with over 50% of potential users open to adopting the product. In other words, the CBGM concept could be a viable alternative to existing products on the market. PreClinical Trials In The Bag Glucotrack’s data so far seems to back up its claims, including its recent 90-day preclinical study demonstrating the sustained accuracy of its CBGM. The second long-term preclinical study for its CBGM showed a Mean Absolute Relative Difference (MARD) of 4.7% at day 90, which is considered highly accurate for a continuous glucose monitor, reports Glucotrack. MARD is a key metric used to assess the accuracy of glucose monitoring devices, measuring the average difference between the CBGM device’s measurement and a reference measurement, most often obtained via capillary blood glucose. Lower values indicate better performance, said Glucotrack. The company said the 90-day preclinical study, which included a larger number of animal subjects and a longer duration than the initial 60-day study announced earlier this year, further validates the CBGM’s sustained accuracy and performance. “We are again very pleased with the performance of our sensor during a long-term preclinical study and look forward to moving into human clinical trials,” stated Paul Goode, PhD, president and CEO of Glucotrack. “Our CBGM’s ability to continuously measure blood glucose for 3 years with accuracy, minimal calibration and without a wearable device represents a significant advancement in glucose monitoring. We believe this technology has the potential to greatly improve the quality of life for people with diabetes by providing a more convenient and discreet monitoring solution,” he said. Cashing In All of these developments seem to have brought Glucotrack investment money; in July, the company secured $4 million in funding from its leading shareholder to support its upcoming first in-human clinical trial. It also helps the company that it has a deep leadership bench and board with years of experience. Take Goode, for starters. He has decades of experience developing innovative medical technologies in the implantables and glucose monitoring space for big-name medical technology companies, including DexCom Inc. (NASDAQ: DXCM), a global continuous glucose monitoring company. Goode is a named inventor on over 150 issued patents, including over 100 relating to Dexcom’s continuous glucose sensing technology. Meanwhile, Mark Tapsak, Ph.D., VP of Sensor Technology, has held senior positions at diabetes management companies, including as senior scientist at DexCom. Further, the bench just got deeper with the appointment of Andy Balo – a former DexCom executive – to the board. Balo brings decades of regulatory, clinical and quality experience in the medical technology industry. In 2002, he joined DexCom as part of the original executive team where he remained for the next 22 years, playing a key role in shaping the company’s future. During his tenure, he was responsible for numerous glucose monitoring regulatory submissions and clinical trials worldwide, and coordinated quality activities across multiple manufacturing facilities. With a forecasted CAGR of 10.3% over 2024-2034, the continuous glucose monitoring market could be poised to take off, and Glucotrack wants to play a role in expanding options for patients with its technology. With preclinical trials already being in the bag, and human trials up next - the company feels its commitment to that goal is progressing steadily toward fruition. Featured photo by Mykenzie Johnson on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 26, 2024 08:30 AM Eastern Daylight Time

Image
1 ... 7071727374 ... 3766